VJNeurology is committed to improving our service to you

Share this video  

VJNeurology is committed to improving our service to you

EAN 2021 | Future challenges for MS research: progressive disease

Mar Tintoré, MD, PhD, Vall d’Hebron University Hospital, Barcelona, Spain, discusses what she thinks is the next big challenge for multiple sclerosis (MS) research. Great developments have been made in the treatment and prevention of MS relapses as well as treat new lesions but Dr Tintoré recommends that understanding the progression of the disease should be the next focus. This interview took place during the European Academy of Neurology 2021 congress.


Consulting services and speaking honoraria from: Almirall, Bayer Schering Pharma, Biogen-Idec, Genzyme, Jansen, Merck-Serono, Novartis, Roche, Sanofi-Aventis, Viela Bio and Teva Pharmaceuticals.
Receipt grants and research supports from: Carlos III Health Institute, Foundation Genzyme, Foundation Salud 2000. Biogen-Idec, Novartis.
Dr Tintoré is co-editor of Multiple Sclerosis Journal-ETC.